Research Antibodies and Reagents Market by Product (Reagent [Sample Preparation (Media, Probe, Buffer), Antibody Production Reagent], Antibody [Type, Source, Research Area]), Technology (Western Blot, ELISA), Application, End User – Global Forecast to 2025
Pune, India – January 14, 2020 /MarketersMedia/ —
Expanding demand for protein therapeutics and personalized medicine, growing incidence of chronic illness, and technological advancements in protein purification methods, has made research antibodies and reagents an effective tool for analysis of disease-causing antigens. Further, growing investments in research activities, rising need for biomarker characterization and identification, and rise in adoption of immunoassays is strongly impacting the growth of research antibodies and reagents market. Meticulous Research® in its latest publication on Research Antibodies and Reagents Market states that the global research antibodies and reagents market will reach $14.56 billion by 2025 growing at a CAGR of 6.0% from 2019 to 2025.
Growth of the global research antibodies and reagents market is mainly attributed to rising proteomics & genomic research studies, increase in the funding for research activities, and growing industry-academia collaborations. In addition, rising demand for protein therapeutics and personalized medicine, rising investment and focus on the area of stem cell research, and rising need for new biomarker identification are also supporting the market growth. Growing research spending in Asia-Pacific and Latin American region is offering significant revenue growth opportunities for market players.
Check complete table of contents with list of table and figures:
To provide efficient analysis, Meticulous Research has segmented this market on the basis of Product (Reagents [Sample Preparation, Antibody Production], Antibodies [by Type, Production, Source, Research Area]), Technology (Western Blot, Immunohistochemistry, Enzyme linked Immunosorbent Assays, Multiplex Immunosorbent Assays, Immunofluorescence, Immunoprecipitation, Flow Cytometry, Others), Application (Proteomics, Drug Discovery & Development, Genomics), End User (Pharmaceutical & Biotechnology Industry, Academic & Research Institutes, Contract Research Organizations), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).
Wherein, geographically, North America commanded the largest share of this market followed by Europe. The large share of North America is mainly attributed to presence of key players in the region, high focus on R&D initiatives for development of genomic medicines, greater adoption of advanced technologies, high level of awareness about new technologies, and growing incidence and prevalence of chronic illness.
In terms of product, the reagents segment accounted for the largest share of the research antibodies and reagents market in 2018. The large share of this segment is mainly attributed to increasing use of reagents in antibody sample preparation and production.
In terms of technology, the western blotting segment accounted for the largest share of this market in 2018. higher adoption of this technology in research assays for initiating developments in diagnosis, therapy, and biomarker discovery are driving the growth in this market.
On the basis of application, the proteomics segment accounted for the largest share of research antibodies and reagents market in 2018 due to high demand for recombinant protein products, increasing production and approvals of monoclonal antibodies, and rising government initiatives for development of protein therapeutics.
Directly Purchase This Premium Report:: https://www.meticulousresearch.com/buy_now.php?pformat=356&vformat=1054
Table of Contents:
1.1. Market Ecosystem
1.1.1. Research Antibodies and Reagents Market
1.1.2. Research Antibodies and Reagents Market, by Product
1.2. Currency and Limitations
1.3. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
3. Executive Summary
4. Market Insights
4.2. Market Dynamics
184.108.40.206. Rising Proteomics and Genomics Research Studies
220.127.116.11. Increase in the Funding for Research Activities
18.104.22.168. Growing Industry-Academia Collaboration
22.214.171.124. High Cost and Time Related to Identification and Development of Potential Antibodies
126.96.36.199. Rising Demand for Protein Therapeutics and Personalized Medicines
188.8.131.52. Rising Investment and Focus on Stem-Cell Research
184.108.40.206. Rising Need for New Biomarker Identification
220.127.116.11. Significant Opportunities from Emerging Asia-Pacific and Latin-American Markets
18.104.22.168. Issues Related to Quality and Stability of Research Antibodies
22.214.171.124. Intense Pricing Pressure on Leading Players
The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence on some of the key players in this market including Abcam plc (U.K.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann La-Roche Ltd (Switzerland), Rockland Immunochemicals Inc. (U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc. (U.S.), Eli Lily and Company (U.S.), Becton Dickinson and Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), GenScript Biotech Corporation (U.S.), Lonza (Switzerland), Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Santa Cruz Biotechnology, Inc. (U.S.), and BioLegend, Inc. (U.S.).
Enquire more or share questions if any before the purchase on this report @
Key questions answered in the report-
Increase in the funding for research activities will propel the research antibodies and reagents market
How does the increase in funding influence the adoption ofresearch antibodies and associated reagents?
How are the leading players benefitted from the increasing research funding?
Pharmaceutical and biotechnology industry accounted for the largest share of the research antibodies and reagents market
What factors are contributing to the frequent usage of research antibodies and reagents in pharmaceutical and biotechnology industry?
What is the pharmaceutical & biotechnology industry growth scenario in different regions?
How does the penetration of research antibodies and reagents in pharmaceutical and biotechnology industry differ from other end users?
The North American research antibodies and reagents market favors both larger and local manufacturers that compete in multiple segments
Who are the top competitors in this market and what strategies do they employ to gain shares?
What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?
What strategies should new companies look to enter this market use to compete effectively?
What are the major drivers, restraints, opportunities, and challenges, in the global research antibodies and reagents market?
What are the geographical trends and high growth regions/ countries?
Leading market players are increasingly focusing on different growth strategies to strengthen their market position
What companies have recently merged/acquired and how will these unions affect the competitive landscape of the research antibodies and reagents market?
What companies have created partnerships and how will these partnerships promote a competitive advantage?
Who are the major players in the global research antibodies and reagents market and what share of the market do they hold?
Who are the local emerging players in the global research antibodies and reagents market and how do they compete with the global players?
Order a copy of Global Research Antibodies and Reagents Market Report 2019 @
More Reports from Same Category by Meticulous Market Research:
In-Vitro Toxicology/Toxicity Testing Market – Global Opportunity Analysis and Industry Forecast (2019-2025)
Email: Send Email
Organization: Meticulous Market Research Pvt. Ltd.
Address: Pune, India
Release ID: 88942673
This news is published on Reuters.